85.93
price up icon0.32%   0.27
 
loading
Spdr Biotech Etf stock is traded at $85.93, with a volume of 9.32M. It is up +0.32% in the last 24 hours and up +3.43% over the past month.
See More
Previous Close:
$85.66
Open:
$84.83
24h Volume:
9.32M
Relative Volume:
0.86
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-1.92%
1M Performance:
+3.43%
6M Performance:
-7.27%
1Y Performance:
-12.91%
1-Day Range:
Value
$84.39
$86.04
1-Week Range:
Value
$84.39
$88.17
52-Week Range:
Value
$66.66
$105.47

Spdr Biotech Etf Stock (XBI) Company Profile

Name
Name
Spdr Biotech Etf
Name
Phone
-
Name
Address
-
Name
Employee
0
Name
Next Earnings Date
Name
Latest SEC Filings
Name
XBI's Discussions on Twitter

Compare XBI with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Exchange Traded Fund icon
XBI
Spdr Biotech Etf
85.93 0 0 0 0 0.00
Exchange Traded Fund icon
VTI
Vanguard Total Stock Market Etf
305.74 417.53B 0 0 0 0.00
Exchange Traded Fund icon
SPY
Spdr S P 500 Etf Trust
621.72 372.57B 0 0 0 0.00
Exchange Traded Fund icon
IVV
Ishares Core S P 500 Etf
624.65 253.41B 0 0 0 0.00
Exchange Traded Fund icon
VB
Vanguard Small Cap Etf
237.58 160.59B 0 0 0 0.00
Exchange Traded Fund icon
QQQ
Invesco Qqq Trust Series 1
553.88 124.43B 0 0 0 0.00

Spdr Biotech Etf Stock (XBI) Latest News

pulisher
Aug 01, 2025

SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Sold by LPL Financial LLC - Defense World

Aug 01, 2025
pulisher
Jul 31, 2025

N.E.W. Advisory Services LLC Acquires New Stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World

Jul 31, 2025
pulisher
Jul 31, 2025

Lyell Wealth Management LP Has $1.18 Million Stock Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World

Jul 31, 2025
pulisher
Jul 30, 2025

Biotech Has Been Stalling. 3 Stocks That Could See Healthy Gains. - MSN

Jul 30, 2025
pulisher
Jul 30, 2025

XBI: Surprise Exit Of A Tough Regulator At The FDA (NYSEARCA:XBI) - Seeking Alpha

Jul 30, 2025
pulisher
Jul 30, 2025

Letko Brosseau & Associates Inc. Has $3.24 Million Stock Position in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World

Jul 30, 2025
pulisher
Jul 30, 2025

Cetera Investment Advisers Buys 5,604 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World

Jul 30, 2025
pulisher
Jul 28, 2025

IFP Advisors Inc Decreases Stock Position in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World

Jul 28, 2025
pulisher
Jul 23, 2025

6 Best Health Care Funds and ETFs for 2025 | Investing - Money/ US News

Jul 23, 2025
pulisher
Jul 23, 2025

(XBI) Trading Advice - news.stocktradersdaily.com

Jul 23, 2025
pulisher
Jul 22, 2025

SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Purchased by Cerity Partners LLC - Defense World

Jul 22, 2025
pulisher
Jul 22, 2025

Cerity Partners LLC Has $1.51 Million Stock Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World

Jul 22, 2025
pulisher
Jul 21, 2025

Envestnet Asset Management Inc. Sells 16,015 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World

Jul 21, 2025
pulisher
Jul 17, 2025

M&T Bank Corp Has $446,000 Stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World

Jul 17, 2025
pulisher
Jul 16, 2025

SPDR S&P Biotech ETF (NYSEARCA:XBI) Stake Lowered by Stratos Wealth Partners LTD. - Defense World

Jul 16, 2025
pulisher
Jul 15, 2025

SPDR S&P Biotech ETF Options Spot-On: On July 15th, 99,099 Contracts Were Traded, With 717.92K Open Interest - 富途牛牛

Jul 15, 2025
pulisher
Jul 14, 2025

Biotech Stocks Are Ready to Rebound. Gilead Sciences and 2 More to Watch Now. - Barron's

Jul 14, 2025
pulisher
Jul 14, 2025

XBI ETF: Riding the Pharma-Biotech Consolidation Wave - AInvest

Jul 14, 2025
pulisher
Jul 14, 2025

Biotech Stocks Are Ready to Rebound. 3 to Watch Now. - Barron's

Jul 14, 2025
pulisher
Jul 13, 2025

(XBI) Investment Analysis and Advice - news.stocktradersdaily.com

Jul 13, 2025
pulisher
Jul 10, 2025

Is SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now? - Yahoo Finance

Jul 10, 2025
pulisher
Jul 06, 2025

Biotech ETFs: Navigating Growth and Stability in a Volatile Landscape - AInvest

Jul 06, 2025
pulisher
Jul 06, 2025

Biotech Looks Ready To Run, But ETFs, Which One? IBB Vs. XBI - Seeking Alpha

Jul 06, 2025
pulisher
Jul 02, 2025

How to Take Advantage of moves in (XBI) - news.stocktradersdaily.com

Jul 02, 2025
pulisher
Jun 25, 2025

Notable ETF Outflow DetectedXBI, INSM, ALNY, BPMC - Nasdaq

Jun 25, 2025
pulisher
Jun 22, 2025

Learn to Evaluate (XBI) using the Charts - news.stocktradersdaily.com

Jun 22, 2025
pulisher
Jun 18, 2025

Dynamic Advisor Solutions LLC Takes $825,000 Position in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World

Jun 18, 2025
pulisher
Jun 16, 2025

3,309 Shares in SPDR S&P Biotech ETF (NYSEARCA:XBI) Bought by Park Avenue Securities LLC - Defense World

Jun 16, 2025
pulisher
Jun 15, 2025

SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Purchased by GAMMA Investing LLC - Defense World

Jun 15, 2025
pulisher
Jun 12, 2025

Should You Invest in the SPDR S&P Biotech ETF (XBI)? - sharewise

Jun 12, 2025
pulisher
Jun 11, 2025

Long Term Trading Analysis for (XBI) - news.stocktradersdaily.com

Jun 11, 2025
pulisher
Jun 09, 2025

Should You Invest in the iShares Biotechnology ETF (IBB)? - sharewise

Jun 09, 2025
pulisher
Jun 09, 2025

How Is Vertex Pharmaceuticals’ Stock Performance Compared to Other Biotech Stocks? - The Globe and Mail

Jun 09, 2025
pulisher
May 29, 2025

Northern Trust Corp Reduces Position in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World

May 29, 2025
pulisher
May 27, 2025

Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)? - Nasdaq

May 27, 2025
pulisher
May 21, 2025

Hedge Funds Question Market Rally, Build Massive Short WallAmer Sports (NYSE:AS), First Solar (NASDAQ:FSLR) - Benzinga

May 21, 2025
pulisher
May 20, 2025

Is Invesco Biotechnology & Genome ETF (PBE) a Strong ETF Right Now? - Nasdaq

May 20, 2025
pulisher
May 19, 2025

Novavax Scores Key FDA Win, Shares Jump 19% As Sanofi Unlocks Milestone Payment - Benzinga

May 19, 2025
pulisher
May 13, 2025

Zacks Investment Ideas feature highlights: Alibaba, JD.com, SPDR S&P Biotech ETF, Merck and Microsoft - TradingView

May 13, 2025
pulisher
May 12, 2025

XBI: Some Tariff Relief Right Now, But Macro Risks Remain In Biotech (NYSEARCA:XBI) - Seeking Alpha

May 12, 2025
pulisher
May 09, 2025

Optimism is Back for Biotech Stocks. This Time, It Could Last. - MSN

May 09, 2025
pulisher
May 09, 2025

MBB Leads With $1.2B Gain as Markets React to UK Trade Deal - TradingView

May 09, 2025
pulisher
May 09, 2025

XBI, EXAS, ALNY, NTRA: Large Outflows Detected at ETF - Nasdaq

May 09, 2025
pulisher
May 09, 2025

(XBI) Investment Analysis - news.stocktradersdaily.com

May 09, 2025
pulisher
May 08, 2025

XBI, Biotech Stocks Retreat: Buy, Hold or Sell? - ETF.com

May 08, 2025
pulisher
May 07, 2025

Vinay Prasad's Appointment To FDA's CBER Triggers Questions Over Future Of Cell And Gene Therapy Regulation - Benzinga

May 07, 2025
pulisher
May 07, 2025

SPDR S&P Biotech ETF Target of Unusually High Options Trading (NYSEARCA:XBI) - Defense World

May 07, 2025
pulisher
May 06, 2025

SPDR S&P Biotech ETF Options Spot-On: On May 6th, 140.63K Contracts Were Traded, With 658.97K Open Interest - 富途牛牛

May 06, 2025
pulisher
May 05, 2025

Optimism Is Back for Biotech Stocks. This Time, It Could Last. - Barron's

May 05, 2025

Spdr Biotech Etf Stock (XBI) Financials Data

There is no financial data for Spdr Biotech Etf (XBI). Check out other stocks for more information.

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
exchange_traded_fund VTV
$175.51
price down icon 0.86%
exchange_traded_fund VUG
$445.04
price down icon 2.23%
exchange_traded_fund IJH
$62.09
price down icon 1.49%
exchange_traded_fund EFA
$87.29
price down icon 0.26%
exchange_traded_fund IWF
$431.91
price down icon 1.93%
exchange_traded_fund QQQ
$553.88
price down icon 1.97%
Cap:     |  Volume (24h):